retatrutide clinical trials efficacy Retatrutide—A Game Changer in Obesity Pharmacotherapy New GLP-3 drug significantly slashes

Individuals with type 2 diabetes for blood sugar control Patients needing assistance with weight loss when diet and exercise are insufficient Adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition (e.g., hypertension, type 2 diabetes, dyslipidemia) As mentioned, studies indicate that GLP-1 is most effective when combined with changes to diet and exercise

Phase 3: peak effect (weeks 20 to 28) Heart rate effects peak around week 24 in the clinical data

reuteri supplementation increased glucose-stimulated GLP-1 secretion by 76%, along with improvements in insulin secretion, in glucose-tolerant adults

You pay for the pen regardless of whether you use the full dose or not, which doesnt leave much room for cost savings through dose adjustments